Media articles and coverage

Clinical Trial 2021 - Press Release

AZ Big Media
Multi-Site Clinical Trial - 2021

We are investigating the safety and effectiveness of the P57 ONE, an investigational non-invasive neuromodulation device for fast-acting moderate to severe anxiety relief.

Actively recruiting as of October 4, 2021.
Estimated enrollment deadline: December 31, 2021

Trial Information

Anxiety comes from a range of stressors that vary from person to person and can affect your ability to get through the day.Arizona State University alumnus Nick Hool wants to help — and so far has helped people in the Phoenix area using a drug-free, anxiety-relief investigational device developed by his neuroscience-research-based startup, Hoolest Performance Technologies.

– Arizona State University, Full Circle

What if you could calm your nerves for a better night sleep all without taking any medication?That's the big idea one Arizona State University Ph.D. student is working on.

Meet the student startup that won $100,000 in ASU/Avnet competition

Hoolest Performance Technologies was the grand winner in Friday's Arizona State University Innovation Open, winning $100,000 from main sponsor Avnet. The Tempe-based student startup targets the 230 million people suffering from performance anxiety, including 6 million who are competitive athletes.

-Phoenix Business Journal
The startup team, comprised of three ASU students, earned $100,000

Hoolest Performance Technologies, made up of three ASU engineering students, won the grand prize at the entrepreneurial competition, beating out four other student-led ventures. The $100,000 investment will go toward creating more of the earbud devices, which block stress by stimulating the vagus nerve.

- Arizona State University